News headlines about ChromaDex Corporation (NASDAQ:CDXC) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. ChromaDex Corporation earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.9337174742705 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Shares of ChromaDex Corporation (NASDAQ CDXC) opened at $6.66 on Friday. The company has a quick ratio of 4.12, a current ratio of 5.03 and a debt-to-equity ratio of 0.01. ChromaDex Corporation has a 52 week low of $2.25 and a 52 week high of $7.10.

A number of brokerages recently weighed in on CDXC. HC Wainwright reiterated a “buy” rating and set a $6.00 price target on shares of ChromaDex Corporation in a research note on Monday, October 2nd. ValuEngine upgraded shares of ChromaDex Corporation from a “sell” rating to a “hold” rating in a research note on Friday, September 8th. Ladenburg Thalmann Financial Services began coverage on shares of ChromaDex Corporation in a research note on Monday, September 25th. They set a “buy” rating and a $7.00 price target for the company. Finally, Zacks Investment Research cut shares of ChromaDex Corporation from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 15th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $6.33.

TRADEMARK VIOLATION WARNING: “ChromaDex Corporation (CDXC) Earning Somewhat Positive News Coverage, Accern Reports” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at

In other ChromaDex Corporation news, major shareholder River Ventures Ltd Champion purchased 731,707 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was purchased at an average price of $4.10 per share, for a total transaction of $2,999,998.70. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 11.59% of the stock is owned by corporate insiders.

ChromaDex Corporation Company Profile

Chromadex Corporation and its subsidiaries ChromaDex, Inc, ChromaDex Analytics, Inc and Spherix Consulting, Inc provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets.

Receive News & Ratings for ChromaDex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChromaDex Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.